Production (Stage)
FibroBiologics, Inc.
FBLG
$0.8087
-$0.0638-7.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.97M | -3.10M | -500.00K | 898.00K | -8.46M |
| Total Depreciation and Amortization | 161.00K | 153.00K | 143.00K | 140.00K | 137.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.09M | 152.00K | -2.21M | -3.45M | 3.63M |
| Change in Net Operating Assets | -1.56M | -279.00K | -44.00K | 463.00K | 419.00K |
| Cash from Operations | -5.28M | -3.07M | -2.61M | -1.95M | -4.28M |
| Capital Expenditure | -43.00K | -99.00K | -11.00K | -66.00K | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -43.00K | -99.00K | -11.00K | -66.00K | -8.00K |
| Total Debt Issued | -- | 9.40M | 0.00 | 0.00 | 574.00K |
| Total Debt Repaid | -- | -115.00K | -172.00K | -172.00K | -115.00K |
| Issuance of Common Stock | -- | 45.00K | 4.64M | 0.00 | 2.82M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 9.33M | 4.47M | -172.00K | 3.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.32M | 6.16M | 1.85M | -2.19M | -1.01M |